Programs & Projects

Validating and Applying Vaccine Investment Tools (Global)


Through previous grants, WDI developed two proof-of-concept tools for evaluating and prioritizing investments in vaccine-related technologies. The Health Investment Prioritization (HIP) Coverage tool estimates changes in vaccination coverage rates by quantifying how well a vaccine presentation addresses technology-addressable barriers to vaccination. The HIP-Valuation tool uses a cost-benefit analysis structure to identify a price window acceptable to both vaccine buyers and sellers, if such a price window exists. In the current project, funded by the Bill & Melinda Gates Foundation, WDI built on the progress to date by using these tools to answer the real-world questions of global health donors and country partners. WDI validated the HIP tools through an external committee of academics and global health donors, and applied the tools to technologies such as microarray patches and thermostable formulations.

Back to Top